Adrenomed looks to bring precision medicine to sepsis 

With Phase II data in hand, Adrenomed is carving out a path into Phase III for what could be the first precision medicine for sepsis. 

Sepsis is the biggest cause of death for patients admitted to the ICU in U.S. hospitals. Yet its standard of care has remained unchanged for decades: early administration of antibiotics and surgical intervention, followed by fluids and vasopressors to combat progression into septic shock, which is typified by hypotension and subsequent organ failure...